Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

RAPTIVA Pages on BioPortfolio:

Biotechnology News RAPTIVA Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/RAPTIVA-news.htm...

BioPortfolio - Raptiva
Raptiva - BioPortfolio - Indepth. ... Companies working in the area of Raptiva from Bioportfolio's Biocorporate database : BioPortfolio Logo. Company Name ...
http://www.bioportfolio.com/indepth/Raptiva.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio - - European Medicines Agency Recommends Suspension ...
Recommends Suspension of Marketing Authorization for Raptiva(R). Tuesday 9 December 2008 ... http://www.prnewswire.co.uk/cgi/news/company?id=236465. ...
http://www.bioportfolio.com/news/European_Medicines_Agency_R...

Wong's BioTech Stock Report - focus on the pipeline Fabrazyme ...
Genentech will co-promote Xolair and Raptiva with Xoma (NASDAQ: XOMA) and Novartis AG ... While the odds of marketing approval looks promising for Raptiva
, ...
http://www.bioportfolio.com/news/biotechsage_6.htm...

BioPortfolio Limited Stakeholder Opinions: Physician perception of ...
Raptiva hit by multifocal leukoencephalopathy side-effect 98 .... Figure 41: Raptiva's weighted score compared to all physicians average scores and ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_16.html...

Psoriasis: Biologics hope to reach 8mill undiagnosed sufferers
The current leading biologics are Biogen Idec and Genentech's Amevive; Serono, Genentech and XOMA's Raptiva; Wyeth and Amgen's Enbrel and Johnson and ...
http://www.bioportfolio.com/news/datamonitor_115.htm...

BioPortfolio Limited Stakeholder Opinions: Physician perception of ...
Raptiva hit by multifocal leukoencephalopathy side-effect 98 ... Table 25: Raptiva's scores by attribute and country, from dermatologists 101 ...
http://www.bioportfolio.com/cgi-bin/acatalog/2075.html...

BioPortfolio Limited Stakeholder Insight: Psoriasis - Biologics ...
Remicade and Raptiva are the clear favorites at third line 99 ... Raptiva's safety profile continues to signal doom for the brand 114 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_19.html...

BioPortfolio News: BioPortfolio BioTrends Research Group, Inc ...
EXTON, Pa., April 10 /PRNewswire/ -- On April 8th, 2009, Genentech and Roche announced the voluntary withdrawal of Raptiva (efalizumab, marketed by ...
http://www.bioportfolio.com/news/company/BioTrends_Research_...

Results from other life science and pharmaceutical sites:

Genentech: Medicines: Raptiva
Raptiva is a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that
lead ...
http://www.gene.com/gene/products/information/immunological/...

Efalizumab - Wikipedia, the free encyclopedia
Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a medication designed to treat psoriasis. As its name implies, it is a recombinant humanized
...
http://en.wikipedia.org/wiki/Efalizumab...

Genentech: Newsroom: Press Releases: News Release April 8, 2009
8 Apr 2009 ... April 8, 2009 -- Genentech, Inc. announced today a phased voluntary withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. ...
http://www.gene.com/gene/news/press-releases/display.do?meth...

FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. ...
8 Apr 2009 ... Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/uc...

RAPTIVA USPI
been observed in patients treated with RAPTIVA (see WARNINGS and .... patients who resumed RAPTIVA treatment upon relapse of psoriasis, 31% (17/55) ...
http://www.gene.com/gene/products/information/pdf/raptiva-pr...

Raptiva (efalizumab) Feb 2009
[UPDATE 04/08/2009] Genentech and FDA notified healthcare professionals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...

Genentech: Investors: Raptiva - Historical Sales
Skip to Content for Raptiva - Historical Sales Menu for Raptiva - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/raptiva.ht...

VOLUNTARY U.S. MARKET WITHDRAWAL OF RAPTIVA® (efalizumab)
8 Apr 2009 ... voluntary withdrawal of the psoriasis medication RAPTIVA ... clinical benefit from RAPTIVA, the balance between benefit and risk in the ...
http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformati...

MEDICATION GUIDE RAPTIVA® (Rap-TEE-vah) (efalizumab) for injection ...
Before you start using RAPTIVA, tell your doctor if you have an infection. During your RAPTIVA treatment, tell your doctor ...
http://www.gene.com/gene/products/information/pdf/raptiva_me...

Roche - Roche and Genentech announce voluntary withdrawal of ...
8 Apr 2009 ... The company's decision is based on the association of Raptiva with an increased risk ... Raptiva is indicated for the treatment of chronic ...
http://www.roche.com/investors/ir_update/inv-update-2009-04-...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.